P. Vonvoigtlander

发表

Chapter 1: Antidepressant and Antipsychotic Agents

P. Vonvoigtlander, 1976 .

Two imidazoquinoxaline ligands for the benzodiazepine site sharing a second low affinity site on rat GABAA receptors but with the opposite functionality

H. K. Im, N. Stratman, P. Vonvoigtlander, 1998, British journal of pharmacology.

Differential affinity of dihydroimidazoquinoxalines and diimidazoquinazolines to the α1β2γ2 and α6β2γ2 subtypes of cloned GABAA receptors

D. Carter, E. Jacobsen, B. Hamilton, 1993 .

Differential potentiation of GABAA receptor function by two stereoisomers of diimidazoquinazoline analogues

J. D. Petke, D. Carter, B. Hamilton, 1992, British journal of pharmacology.

Axonal transport: reciprocal effects of neuroleptics and D-amphetamine.

P. Vonvoigtlander, 1974, Brain research.

U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

R. Lahti, J. H. Ludens, P. Vonvoigtlander, 1983, The Journal of pharmacology and experimental therapeutics.

Effect of the anticonvulsant U-54494A on cortical neuron excitability: comparison to the kappa agonist U-50488H.

M. Piercey, J. T. Lum, P. Vonvoigtlander, 1992, Life sciences.

Competitive irreversible inhibition of dopamine uptake by 6-hydroxydopamine.

P. Ruppel, P. Vonvoigtlander, D. Decker, 1993, Research communications in chemical pathology and pharmacology.

Structure activity relationships of peroxynitrite scavengers an approach to nitric oxide neurotoxicity.

V. Sethy, G. Fici, P. Vonvoigtlander, 1994, Research communications in chemical pathology and pharmacology.

Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.

P. Vonvoigtlander, E. Losey, H. J. Triezenberg, 1975, The Journal of pharmacology and experimental therapeutics.

Azulenyl nitrones: colorimetric detection of oxyradical end products and neuroprotection in the gerbil transient forebrain ischemia/reperfusion model.

E. Hall, T. Fleck, P. Vonvoigtlander, 1998, Free radical biology & medicine.

Synthetic Studies towards A trans-3,4-Diamine Derivative of Piperidine Mimicking Buspirone

Arun K. Ghosh, J. Blinn, P. Vonvoigtlander, 1994 .

Regioselective and stereoselective syntheses of 1,2,3-triaminocyclohexane derivatives

C. Chidester, S. Mizsak, P. Vonvoigtlander, 1993 .

Prostaglandin E2, cyclic adenosine monophosphate and morphine analgesia

P. Vonvoigtlander, E. Losey, 1977, Brain Research.

Alprazolam: Review of pharmacological, pharmacokinetic, and clinical data

P. Vonvoigtlander, R. N. Straw, 1985 .

Stereocontrolled syntheses of some conformationally restricted analogs of serotonin

S. Mizsak, T. Scahill, P. Vonvoigtlander, 1991 .

U‐48,753E: A potent, structurally novel antidepressant‐like agent

P. Vonvoigtlander, D. Gay, E. Losey, 1983 .

6-hydroxydopa depletes both brain epinephrine and norepinephrine: interactions with antidepressants.

P. Vonvoigtlander, E. Losey, 1978, Life sciences.

Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.

E. Hall, J. Palmer, G. Sawada, 1997, The Journal of pharmacology and experimental therapeutics.

6-(Substituted-amino)-4H-s-triazolo[4,3-a][1,4]benzodiazepines and 4-(substituted-amino)-6H-s-triazolo[4,3-a][1,4]benzodiazepines with potential antianxiety activity.

G. Evenson, P. Vonvoigtlander, J. Hester, 1980, Journal of medicinal chemistry.

1-(Aminoalkyl)-6-aryl-4-H-s-triazolo[4,3-a][1,4]benzodiazepines with antianxiety and antidepressant activity.

P. Vonvoigtlander, J. Hester, A. Rudzik, 1980, Journal of medicinal chemistry.

Properties of a selective kappa agonist, U-50,488H.

R. Lahti, C. Barsuhn, P. Vonvoigtlander, 1982, Life sciences.

Air‐induced writhing: A rapid broad spectrum assay for analgesics

Richard A. Lewis, P. Vonvoigtlander, Philip F. VonVoigtlander, 1982 .

4-(p-Bromophenyl)-4-(dimethylamino)-1-phenethylcyclohexanol, an extremely potent respresentative of a new analgesic series.

D. Lednicer, P. Vonvoigtlander, 1979, Journal of Medicinal Chemistry.

Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.

M. Piercey, R. Mccall, K. Merchant, 1996, The Journal of pharmacology and experimental therapeutics.

Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality.

J. D. Petke, W. Zhong, D. Carter, 1999, Journal of medicinal chemistry.

High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the gamma-aminobutyric acid A/benzodiazepine receptor complex.

J. D. Petke, D. Carter, V. Sethy, 1996, Journal of medicinal chemistry.

Thyroid hormonal modulation of the binding and activity of the GABAA receptor complex of brain

J. V. Martin, H. K. Im, P. Vonvoigtlander, 1996, Neuroscience.

Involvement of biogenic amines with the mechanisms of novel analgesics

Richard A. Lewis, P. Vonvoigtlander, G. Neff, 1983, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Reversal by tirilazad mesylate (U-74006F).

E. Hall, P. Vonvoigtlander, P. K. Andrus, 1993, Molecular and chemical neuropathology.

U-90042, a sedative/hypnotic compound that interacts differentially with the GABAA receptor subtypes.

M. Smith, D. Carter, W. Im, 1995, The Journal of pharmacology and experimental therapeutics.

Comparison of pyrrolidinyl and piperidinyl benzamides for their anticonvulsant activity and inhibitory action on sodium channel

Richard A. Lewis, W. Im, P. Vonvoigtlander, 1992, British journal of pharmacology.

2,4-Dihydro-6-phenyl-1H-s-triazolo[4,3-a][1,4]benzoidiazepin-1-ones with antianxiety and antidepressant activity.

P. Vonvoigtlander, J. Hester, A. Rudzik, 1980, Journal of medicinal chemistry.

8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines with substituents at C-4

P. Vonvoigtlander, J. Hester, A. Rudzik, 1980 .

Anticonvulsant and related effects of U-54494A in various seizure tests.

W. Fischer, R. Bodewei, P. Vonvoigtlander, 1993, The Journal of pharmacology and experimental therapeutics.

PNU-107484 A with a isoform-dependent functional changes in a x b 2 g 2 subtypes of rat recombinant GABAA receptors

D. Carter, G. Bundy, H. K. Im, 1997 .

Enhancement of anesthetic effect of halothane by spiradoline, a selective kappa-agonist.

C. Difazio, J. Moscicki, P. Vonvoigtlander, 1988, Anesthesia and Analgesia.

Synthesis and biological activity of △Phe4-enkephalins

Y. Shimohigashi, C. Stammer, T. Costa, 2009 .

Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1 gamma 2, beta 2 gamma 2 and alpha 1 beta 2 gamma 2 subtypes of cloned gamma-aminobutyric acid type A receptors.

D. Carter, B. Hamilton, H. K. Im, 1993, Molecular pharmacology.

Effects of lazaroids and a peroxynitrite scavenger in a cell model of peroxynitrite toxicity.

G. Fici, P. Vonvoigtlander, J. Althaus, 1997, Free radical biology & medicine.

Effects of U‐50488H, a Selective k‐Analgesic, on the Minimum Anesthetic Concentration (MAC) of Halothane in the Rat

C. Difazio, E. Miller, P. Vonvoigtlander, 1987, Anesthesia and analgesia.

The effects of depolarizing agents and neuropeptides on dopamine release from striatal synaptosomes

P. Vonvoigtlander, E. Losey, Elizabeth G. Losey, 1982 .

4-Amino-4-arylcyclohexanones and their derivatives, a novel class of analgesics. 1. Modification of the aryl ring.

D. Lednicer, P. Vonvoigtlander, D. Emmert, 1980, Journal of medicinal chemistry.

Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid.

R. Lewis, P. Vonvoigtlander, P. VonVoigtlander, 1988, The Journal of pharmacology and experimental therapeutics.

D1 dopamine receptor activity of anti-parkinsonian drugs.

V. Sethy, G. Fici, P. Vonvoigtlander, 1997, Life sciences.

Effects of analgesics, endorphins, and other drugs in a 3H‐serotonin binding assay

P. Vonvoigtlander, D. Gay, 1982 .

On the use of selective neurotoxic amine analogs to measure the blockade of norepinephrine and 5-hydroxytryptamine uptake systems by antidepressants.

P. Vonvoigtlander, E. Losey, 1976, Research communications in chemical pathology and pharmacology.

Hydroxyl radical production and lipid peroxidation paralles selective post‐ischemic vulnerability in gerbil brain

E. Hall, P. von Voigtlander, P. Vonvoigtlander, 1993, Journal of neuroscience research.

U-54494A reduces 4-AP-induced afterdischarges of CA1 pyramidal cells in the hippocampal slice of the rat.

W. E. Hoffmann, P. Vonvoigtlander, M. Camacho-Ochoa, 1992, Life sciences.